Association between temporal muscle thickness and clinical outcomes in patients with newly diagnosed glioblastoma.

Geon AnStephen AhnJae-Sung ParkSin- Soo JeunYong- Kil Hong

Published in: Journal of cancer research and clinical oncology (2020)

Our findings suggest that TMT can be a useful prognostic biomarker for clinical outcomes in GBM patients. Further preclinical and clinical studies could help elucidate this association of sarcopenia with clinical outcomes in GBM patients.

Keyphrases

newly diagnosed
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
skeletal muscle
stem cells
mesenchymal stem cells
optical coherence tomography
bone marrow
patient reported
community dwelling